Delivery Order 36F79722D0128-36C25923F0398

Award Date 8/31/23
Potential Completion Date 8/31/24
Potential Value $33K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Castleton, IN 46256, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $130,466.74 firm fixed price delivery order awarded by the Veterans Integrated Service Network 19 (VISN 19) of the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for a Blood Gas Maintenance and Rental Agreement, which provides critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and...
This is a federal contract award from the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $1,153,746.18 delivery order contract is for the provision of reagents under the VA's Critical Analyzers, Laboratory (FSS-66-III) General Services Administration (GSA) Schedule, with a firm fixed price pricing type. The contract, which has no...
This federal contract award to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and related laboratory equipment, was made by the Department of Veterans Affairs (VA) through Veterans Integrated Service Network 23. The $323,373.27 firm fixed-price purchase order is for the supply of reagents with a period of performance ending on March 31, 2018. The contract has no set-aside designation. Roche Diagnostics has a long history of providing critical...
This is a $28,184.58 firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the delivery of reagents and has a period of performance through September 21, 2024. Roche Diagnostics has previously received multiple federal contract awards, including through the General Services Administration...
This federal contract award is for reagents with a ceiling value of $34,397.44. The prime contractor is Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract was awarded by the U.S. Department of Veterans Affairs (VA) through the Veterans Integrated Service Network 1 (VISN 1), with an ultimate completion date of August 14, 2025. Roche...
This federal contract award was made by the Veterans Integrated Service Network 22 of the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $234,775.55 Firm Fixed Price delivery order contract is under Roche's existing General Services Administration (GSA) Schedule contract for in vitro diagnostics, reagents, and test kits (FSS-65-VII). The...
This is a federal contract award to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, valued at $505,960.52, is a Delivery Order awarded by the U.S. Department of Veterans Affairs (VA) under Roche's General Services Administration (GSA) Schedule contract for In Vitro Diagnostics, Reagents, and Test Kits (FSS-65-VII). The contract is for the provision of reagents, with a...
This is a Delivery Order awarded by the Veterans Integrated Service Network 22 (VISN 22) of the U.S. Department of Veterans Affairs to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, valued at $923,798.62, is for the provision of BLOOD REAGENTS and is placed against Roche's General Services Administration (GSA) Schedule contract for Critical Analyzers, Laboratory...
This is a delivery order awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for reagents and supplies. The $187,784.99 firm fixed price contract has a period of performance through March 4, 2025 and was awarded on February 1, 2023. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, has provided laboratory instruments, reagents, test kits, and associated products and services to various federal...
This is a federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, by the U.S. Department of Veterans Affairs (VA) through the Veterans Integrated Service Network 16 (VISN 16). The contract, awarded on October 1, 2016, is a Delivery Order under Roche's General Services Administration (GSA) Schedule 66 contract for Scientific Equipment and Services. The contract has a ceiling value of $99,348.47 and an ultimate completion date of May 2, 2018. The contract...

This federal contract award, issued by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 19, is for the provision of Roche blood gas reagents and rental equipment. The $33,328.55 firm-fixed-price delivery order is not designated as a set-aside contract. The prime contractor is Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, and laboratory instruments. This contract is part of a larger Indefinite Delivery Vehicle (IDV) established under the GSA's In Vitro Diagnostics, Reagents, Test (FSS-65-VII) schedule, allowing the VA to efficiently acquire Roche's medical diagnostic technologies through pre-negotiated pricing and terms. The 13-month contract has an ultimate completion date of August 31, 2024.

Generated 4/21/25, 3:48 AM